Clinical biology of the pituitary adenoma

S Melmed, UB Kaiser, MB Lopes, J Bertherat… - Endocrine …, 2022 - academic.oup.com
All endocrine glands are susceptible to neoplastic growth, yet the health consequences of
these neoplasms differ between endocrine tissues. Pituitary neoplasms are highly prevalent …

Aggressive pituitary tumours and pituitary carcinomas

G Raverot, MD Ilie, H Lasolle, V Amodru… - Nature Reviews …, 2021 - nature.com
Although usually benign, anterior pituitary tumours occasionally exhibit aggressive
behaviour, with invasion of surrounding tissues, rapid growth, resistance to conventional …

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case–control study of 410 patients with 8 years post-operative follow-up

J Trouillas, P Roy, N Sturm, E Dantony… - Acta …, 2013 - Springer
Pituitary adenomas are currently classified by histological, immunocytochemical and
numerous ultrastructural characteristics lacking unequivocal prognostic correlations. We …

Aggressive pituitary adenomas—diagnosis and emerging treatments

A Di Ieva, F Rotondo, LV Syro, MD Cusimano… - Nature Reviews …, 2014 - nature.com
The WHO categorizes pituitary tumours as typical adenomas, atypical adenomas and
pituitary carcinomas, with typical adenomas constituting the major class. However, the WHO …

[HTML][HTML] Clinical factors involved in the recurrence of pituitary adenomas after surgical remission: a structured review and meta-analysis

F Roelfsema, NR Biermasz, AM Pereira - Pituitary, 2012 - Springer
To study the currently available data of recurrence rates of functioning and nonfunctioning
pituitary adenomas following surgical cure and to analyze associated predisposing factors …

Personalized immunotherapy against several neuronal and brain tumors

S Kuttruff-coqui, T Weinschenk, J Fritsche… - US Patent …, 2021 - Google Patents
2014-11-12 Assigned to IMMATICS BIOTECHNOLOGIES GMBH reassignment IMMATICS
BIOTECHNOLOGIES GMBH ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT …

Epidemiology and etiopathogenesis of pituitary adenomas

ED Aflorei, M Korbonits - Journal of neuro-oncology, 2014 - Springer
Pituitary adenomas are usually benign monoclonal tumours presenting either due to
hypersecretion of pituitary hormones, and/or due to local space occupying effects and …

Management of dopamine agonist-resistant prolactinoma

D Maiter - Neuroendocrinology, 2019 - karger.com
Dopamine agonists are usually very effective in the treatment of prolactinomas.
Nonetheless, a subset of individuals does not respond satisfactorily to these agents, and this …

Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification

G Raverot, E Dantony, J Beauvy… - The Journal of …, 2017 - academic.oup.com
Background Most pituitary neuroendocrine tumors (PitNETs) show benign behavior, but a
substantial number are invasive, recur, or resist medical treatment. Based on a retrospective …

Pituitary carcinoma: difficult diagnosis and treatment

AP Heaney - The Journal of Clinical Endocrinology & …, 2011 - academic.oup.com
Context: Although pituitary tumors are common, pituitary carcinoma is very rare and is only
diagnosed when pituitary tumor noncontiguous with the sellar region is demonstrated …